Robert Naclerio to Omalizumab
This is a "connection" page, showing publications Robert Naclerio has written about Omalizumab.
Connection Strength
0.136
-
A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis. Rhinology. 2010 09; 48(3):318-24.
Score: 0.090
-
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines. Allergy. 2021 08; 76(8):2337-2353.
Score: 0.047